INTRODUCTION {#sec1-1}
============

Male fertility requires the production of a sufficient number of normally functioning sperm that can move through the female reproductive tract and bind to and penetrate the zona pellucida of the oocyte, which subsequently forms a viable fetus. A defect in any aspect of sperm function, including sperm concentration, motility, acrosome reaction, binding and penetrating the zona pellucida, and chromatin integrity, could lead to male infertility.[@ref1][@ref2]

C-type natriuretic peptide (*CNP*) is a peptide 22 amino acids in length that acts as a local paracrine or autocrine regulator.[@ref3] *CNP* was first isolated from the porcine brain as a small protein by Sudoh *et al*. in 1990.[@ref4] By comparing the expression of *proCNP* and *CNP* in extracts from 32 different porcine tissues, Nielsen *et al*.[@ref5] found that the highest peptide concentrations were in male reproductive tissues (such as the epididymis, seminal vesicles and prostate); *CNP* mRNA in the seminal vesicles and epididymis was 125-fold higher than in other tissues. Moreover, Chrisman *et al*.[@ref6] reported that *CNP* concentrations in porcine seminal plasma and seminal vesicle fluid were 2000- and 100,000-fold greater than those found in the porcine brain, respectively. In addition, further studies showed that the concentration of *CNP* in human seminal plasma was \>200-fold higher than that of blood plasma.[@ref7] The high expression level of *CNP* specifically in male reproductive organs indicates the importance of *CNP* in male reproduction.

However, the specific effect of *CNP* on sperm function is unclear. In this study, we detected the distribution of *CNP*/natriuretic peptide receptor-B (*NPR-B*) in human ejaculated spermatozoa and evaluated the influence of *CNP* on sperm function *in vitro*, including motility and acrosome reaction.

MATERIALS AND METHODS {#sec1-2}
=====================

 {#sec2-1}

### Human semen and testes samples {#sec3-1}

Human semen samples were collected from consenting donors at the Hubei human sperm bank of China. All of the semen samples met the World Health Organization 1999 criterion[@ref8] for normozoospermia and were collected by masturbation after 3-5 days of abstinence. Ethical approval for human study was completed from the institutional review board. Semen samples were diluted 1:5 with Ham\'s F-10 medium (Sigma-Aldrich, St. Louis, MO, USA) and centrifuged for 5 min at 800 *g*. The supernatant was discarded and the remaining pellet resuspended with fresh Ham\'s F-10 medium (wash). The washed human sperm suspension was used for analysis.

Human testes were from patients undergoing testicular biopsy in the Center for Reproductive Medicine of Tongji Medical College. After pathologic evaluation, testicular biopsy specimens showed normal spermatogenesis. The study required informed consent by patients and was permitted by the Ethics Committee.

### Immunofluorescence of human sperm {#sec3-2}

Smears of human ejaculated spermatozoa were used to analyze the distribution of CNP/NPR-B by using indirect immunofluorescence, noting the presence or absence of staining on the sperm. The indirect immunofluorescence technique was performed as previously described.[@ref9] Briefly, the sperm were air-dried, fixed, permeabilized, treated with serum and probed with either anti-human CNP or NPR-B polyclonal antibodies (1:200) (Santa Cruz Biotechnology Inc., Santa Cruz, CA). Fluorescein isothiocyanate-conjugated secondary antibodies (1:100) (Boster Biotechnology Co. Ltd., Wuhan, China) were used to detect CNP/NPR-B. For the negative control, 0.01 mol l^−1^ phosphate-buffered saline (PBS; pH 7.4) was used instead of the primary antibody. The immunohistochemical results were assessed using a confocal laser scanning microscope (Tokyo, Japan) equipped with a FV10-ASW 2.1 Viewer.

### Real-time reverse transcription polymerase chain reaction {#sec3-3}

Total RNA was extracted from healthy human ejaculated spermatozoa. The experiment was repeated 3 times to estimate expression stability. Real-time reverse transcription polymerase chain reaction (RT-PCR) was performed as previously described.[@ref10] Briefly, each sample was pipetted into 1 ml Trizol reagent. Total RNA was reverse transcribed into first-strand cDNA using a first strand cDNA Synthesis Kit (Toyobo, Tokyo, Japan). Each RT reaction mixture contained 3 μg of total RNA, 1× RT buffer, 0.5 mmol l^−1^ of each dNTP, 1 μg of oligo d(T)20, 400 IU Moloney murine leukemia virus reverse transcriptase, 40 IU RNasin and H~2~ O to a final volume of 40 μL. The reaction mixture was incubated at 42°C for 20 min, then at 99°C for 5 min. The primer pairs used in RT-PCR are listed in [**Table 1**](#T1){ref-type="table"}.
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### Sodium dodecyl sulfate-polyacrylamide gelelectrophoresis and immunoblotting {#sec3-4}

Total protein of sperm samples and testes were obtained by using radio-immunoprecipitation assay lysis buffer according to the manufacturer\'s instructions. Concentration of protein was estimated by an Enhanced bicinchoninic acid assay kit. Equal amounts of protein samples were loaded to 10% sodium dodecyl sulfate-polyacrylamide gelelectrophoresis, and electrophoretic transfer of proteins to a nitrocellulose membrane was done by using a wet transfer. Immunodetection of NPR-B was carried out through incubating the membrane with NPR-B polyclonal antibody (dilution at 1:200) and developed with a secondary antibody conjugated with HRP (dilution at 1:7500). The reactive bands were detected by an enhanced chemiluminescence reagent kit according to the manufacturer\'s instructions.

### Determination of human sperm motility {#sec3-5}

The washed human sperm suspension described above (*n* = 15) was divided into three aliquots. The sperm suspensions were incubated with either 10^−6^ or 10^−7^ mol l^−1^ CNP (Sigma-Aldrich) diluted with Ham\'s F-10 medium or with Ham\'s F-10 medium alone. Then, the sperm suspensions were incubated at 37°C in 5% CO~2~ incubator. The motility of sperm was analyzed at 5 min, 30 min, 60 min, 120 min, and 240 min for each group. The sperm motility was determined as the percentage of progressively motile sperm, in which over 200 sperm were counted.

### Determination of human sperm acrosome status {#sec3-6}

Acrosome reaction was determined by using the Coomassie brilliant blue staining technique described by Feng *et al*.[@ref11] The washed human sperm suspension (*n* = 10) was incubated for 1 h to induce capacitation at 37°C in 5% CO~2~ incubator. Next, the sperm suspension was divided into three groups as described above. The acrosome reaction of sperm was analyzed at 0 h, 3 h, and 6 h for each group. Briefly, the sperm was air-dried, fixed with 4% paraformaldehyde in PBS (pH 7.4) for 10 min, and washed 3 times with PBS. Slides were stained for 20 min with aqueous 0.05% Coomassie brilliant blue R-250 (Boster Biotechnology Co. Ltd., Wuhan, China) in 3.5% perchloric acid; they were then rinsed with distilled water and covered with coverslips under neutral resin. The acrosomal status was viewed under a light microscope at ×1000 magnification. A minimum of 200 sperm cells was analyzed for the presence or absence of an acrosome reaction per slide.

### Statistical analysis {#sec3-7}

The sperm motility and acrosome reaction were evaluated by one-way analysis of variance after checking for normal distributions by means of the Kolmogorov-Smirnov test. All statistical tests were two-tailed, and *P* \< 0.05 were considered to be statistically significant. All analyses were performed using the SPSS software version 17 computer program (SPSS software, Chicago, IL, USA).

RESULTS {#sec1-3}
=======

 {#sec2-2}

### Protein and gene expression of CNP/natriuretic peptide receptor-B in human sperm {#sec3-8}

Under a confocal laser scanning microscope, we observed green fluorescence in the acrosomal region of the head and the membrane of the front-end tail of sperm when we detected the expression of NPR-B, but there was no signal of green fluorescence when we detected the expression of CNP ([**Figure 1a**](#F1){ref-type="fig"}). The results indicated that NPR-B, the specific receptor of CNP, was localized in the acrosomal region of the head and the membrane of the front-end tail of the sperm but that CNP was not expressed in human sperm. Moreover, NPR-B *p*rotein can also be detected in human sperm and testes with a Western Blot ([**Figure 1b**](#F1){ref-type="fig"}). The RT-PCR results showed that there was gene expression of *NPR-B* in human sperm, but not of *CNP* ([**Figure 2**](#F2){ref-type="fig"}), which matched the confocal laser scanning microscope results described above.

![Protein location of CNP/NPR-B in human sperm. (**a**) Immunolocalization of CNP/NPR-B in human sperm. FITC-conjugated secondary antibodies were used for the detection of CNP/NPR-B. DIC images were acquired in parallel and served as the control for sperm morphology. The fluorescence image was merged with the DIC image to show the exact location of the fluorescence. Arrowheads indicate the location of CNP/NPR-B in human sperm. Indirect immunofluorescence ×600. (**b**) Western Blotting analysis of NPR-B in human testis and human sperm. CNP: C-type natriuretic peptide; NPR-B: natriuretic peptide receptor-B; FITC: fluorescein isothiocyanate; GAPDH: glyceraldehyde-3-phosphate dehydrogenase.](AJA-18-80-g002){#F1}

![Semiquantitative RT-PCR analyses of *CNP* and *NPR-B* expression in sperm or testes coamplified with *GAPDH*. RT-PCR: reverse transcription polymerase chain reaction; *CNP*: C-type natriuretic peptide; *NPR-B*: natriuretic peptide receptor-B, *GAPDH*: glyceraldehyde-3-phosphate dehydrogenase.](AJA-18-80-g003){#F2}

### C-type natriuretic peptide can stimulate the motility of human sperm {#sec3-9}

Because the specific receptor (*NPR-B*) of *CNP* was present in the sperm, we hypothesized that *CNP* may be a key player in sperm function. Therefore, we assessed the motility of sperm after culture in the presence of different CNP concentrations (0, 10^−7^ and 10^−6^ mol l^−1^) at 5 min, 30 min, 60 min, 120 min, and 240 min. As shown in [**Figure 3**](#F3){ref-type="fig"}, compared with the control, the motility of the 10^−7^ and 10^−6^ mol l^−1^ CNP-treated groups were higher 30 min after CNP was added to the sperm suspension. The changes were dose-dependent, as CNP 10^−6^ mol l^−1^ showed a more significant difference (*P* = 0.001) than did CNP 10^−7^ mol l^−1^ (*P* = 0.019).

![Influence of CNP on the motility of human sperm (X̄ ± standard deviation, *n* = 15, \**P* \< 0.05, \*\**P* \< 0.01, compared with the control group). As shown in the graph, compared with the control, percentage of progressively motile sperm (WHO motility class a + b) was increased at 30 min after CNP was added to the sperm suspension, and the changes were dose-dependent. CNP: C-type natriuretic peptide; WHO: World Health Organization.](AJA-18-80-g004){#F3}

### C-type natriuretic peptide can promote the acrosome reaction of human sperm {#sec3-10}

Having established the expression of the specific receptor of CNP on the sperm surface, we hoped to demonstrate its role in the sperm acrosome reaction. Therefore, we monitored the sperm acrosome reaction using Coomassie brilliant blue staining techniques. As shown in [**Figure 4a**](#F4){ref-type="fig"}, the percentage of sperm that underwent an acrosome reaction began to increase compared with the control after incubation for 3 h with different CNP concentrations (10^−7^ and 10^−6^ mol l^−1^), and it was markedly increased after 6 h of incubation with CNP at all concentrations. Moreover, the percentage of sperm undergoing an acrosome reaction was more significantly increased in the 10^−6^ mol l^−1^ CNP (*P* \< 0.0001) than in the 10^−7^ mol l^−1^ *CNP* (*P* = 0.007) group, and the changes were dose-dependent. The acrosome region was stained blue in acrosome-intact sperm but remained unstained or stained light purple in acrosome-reacted sperm[@ref11] ([**Figure 4b**](#F4){ref-type="fig"}).

![Effect of CNP on the human sperm acrosome reaction by the Coomassie brilliant blue staining method. (**a**) Data showing the percentage of acrosome-reacted cells at different incubation times under different concentrations of CNP (0, 10−7 and 10−6 mol l−1). (x̄ ± standard deviation, *n* = 10, \**P* \< 0.05, \*\**P* \< 0.01, compared with the control group). (**b**) The acrosome region is stained blue in the acrosome-intact sperm but unstained or stained light purple in the acrosome-reacted sperm, Original magnification ×1000. CNP: C-type natriuretic peptide.](AJA-18-80-g005){#F4}

DISCUSSION {#sec1-4}
==========

Natriuretic peptides belong to a family of small proteins that play a major role in the modulation of natriuresis, diuresis, and vasodilatation.[@ref12] The natriuretic peptide family in mammals consists of three structurally related peptides: atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP), and CNP. All three natriuretic peptide members exert their biological effects through two different membrane-bound natriuretic peptide receptors (NPR-A and NPR-B). ANP and BNP have been shown to bind preferentially to NPR-A, whereas CNP displays a greater affinity for NPR-B, which is considered to be the specific receptor of CNP.[@ref13] NPR-A binds natriuretic peptides at a stoichiometry of 2:1 with a rank natriuretic peptide preference of: ANP ≥ BNP \>\>CNP; NPR-B binds natriuretic peptides with a selectivity preference of CNP \>\>ANP ≥ BNP.[@ref14] CNP does not increase guanosine 3',5'- monophosphate accumulation in cells expressing human NPR-A, the affinity of CNP for NPR-B is 50- or 500-fold higher than ANP or BNP, respectively.[@ref15]

C-type natriuretic peptide has been shown to play a key role in female reproduction. *NPR-B*^−/−^ female mice are sterile, which is caused by the failure to properly develop functional ovaries and uteruses.[@ref16] In rats, the expression of *CNP* in uterine tissue is modulated by the estrous cycle, with the highest expression during proestrus.[@ref17] An intraperitoneal infusion of estradiol increases uterine *CNP* in a dose-dependent manner in ovariectomized mice.[@ref18] Furthermore, *CNP* produced by mural granulosa cells and *NPR-B* produced by cumulus cells can prevent the precocious meiotic maturation of oocytes, which is critical for maturation and ovulation synchrony and normal female fertility.[@ref19] Moreover, CNP is capable of stimulating preantral and antral follicle growth; therefore, CNP treatment could provide an alternative therapy for female infertility in place of follicle-stimulating hormone.[@ref20]

The key role of *CNP* in female reproduction has been demonstrated, but the effect of *CNP* on male reproduction has been reported in few studies, though there are high expression levels of *CNP* specifically in male reproductive organs. To determine the role of *CNP/NPR-B* signaling in male reproduction, Sogawa *et al*.[@ref21] investigated phenotype of Npr2-deficient short-limbed-dwarfism (Npr2slw/slw) mice, and found that the developmental onset and acquisition of spermatogenic function is delayed in Npr2slw/slw mutant mice. In the male reproductive system, both *CNP* and its receptor *NPR-B* are expressed in human testes, *CNP* is mainly expressed in Leydig cells,[@ref22] yet *NPR-B* is mainly in Sertoli cell.[@ref23] The occurrence of *CNP*, as well as its receptor, in human testes points to a local role of the peptide to regulate the function of Sertoli cells. In cultured rat Sertoli cells, CNP supplementation can stimulate the gene expression of androgen-binding protein/inhibin B/transferrin.[@ref24] Moreover, CNP secreted by rat Leydig and germ cells into the blood-testis barrier (BTB) microenvironment regulates BTB dynamics during spermatogenesis.[@ref23]

In this study, we first investigated the expression of *CNP/NPR-B* in human ejaculated spermatozoa. The results showed that NPR-B was highly localized to the acrosomal region of the head and the membrane of the front-end tail of the sperm, but there was no CNP signal in human sperm. As we described above, *CNP* is a local paracrine or autocrine regulator that mediates its biological effects via the specific membrane-bound *NPR-B*; therefore, we hypothesized that CNP, which shows a high concentration in the seminal plasma, may affect sperm motor function either by binding to NPR-B located in the region of mitochondria or by the acrosome reaction through NPR-B localized in the head.

To prove the function of *CNP/NPR-B* in the sperm mentioned above, we used different concentrations of CNP to stimulate human sperm function. The concentrations of CNP chosen were referred to in an article that mentioned the effective concentrations of CNP in its studies.[@ref24] Our results showed that CNP could significantly increase the motility of sperm at 30 min and induce an acrosome reaction at 6 h. Furthermore, these effects were dose-dependent. This part of our study supported our hypothesis mentioned above. It has been reported that sperm motility and the acrosome action are the crucial parameters for fertility. *CNP*, which plays a role in sperm motility and the acrosome reaction, may also affect sperm fertility, but further studies are needed to confirm this hypothesis.

The mechanism of the biological effects of *CNP/NPR-B* may be generally associated with the intracellular accumulation of cGMP.[@ref3] cGMP is produced by different isoforms of the enzyme guanylate cyclase (GC). Natriuretic peptides (ANP and CNP) bind to and activate particulate GCs, whereas nitric oxide (*NO*) and carbon monoxide activate a soluble form of GC (sGC).[@ref25] The specific relevance of the cGMP system for reproductive functions has been recently demonstrated by the successful use of sildenafil (Viagra), an inhibitor of cGMP-specific phosphodiesterase type 5, for the treatment of erectile dysfunction.[@ref26] In the testes, cGMP signal transduction pathways are involved in a variety of local functions, based on autocrine or paracrine effects. In particular, cGMP has been suggested to influence the motility in spermatozoa,[@ref27] testosterone syntheses in Leydig cells,[@ref28] development of testicular germ cells,[@ref29] dilatation of testicular blood vessels[@ref30] and so on. Miraglia *et al*.[@ref31] reported that *NO* exerted a significant enhancing effect on progressive motility of human spermatozoa, which is medicated by activation of the sGC/cGMP pathway.

CONCLUSION {#sec1-5}
==========

Our work has investigated the expression of *CNP/NPR-B* in human ejaculated spermatozoa and revealed that *CNP/NPR-B* can affect sperm motility and acrosome action, which are closely related to the reproductive function of males. The function of *CNP/NPR-B* is usually mediated by cGMP, but this pathway in spermatozoa needs to be proved. Our future studies will focus on the signal conduction of CNP/NPR-B in sperm.
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